| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Aprea Therapeutics Inc is a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers. It develops small molecule inhibitors designed to exploit...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Aprea Therapeutics (NASDAQ:APRE) through any online brokerage.
Other companies in Aprea Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Aprea Therapeutics has a consensus price target of $2.80.
The stock price for Aprea Therapeutics (NASDAQ: APRE) is $0.6206 last updated October 16, 2026 at 4:42 PM EDT.
There are no upcoming dividends for Aprea Therapeutics.
Aprea Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Aprea Therapeutics.
Aprea Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
